SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 11:21 am Sale | 2020-12-31 | 13G | Evofem Biosciences, Inc. EVFM | SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC | 0 0.000% | -1,791 (Position Closed) | Filing |
| 2020-02-13 1:46 pm Purchase | 2019-12-31 | 13G | Evofem Biosciences, Inc. EVFM | SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC | 1,791 7.173% | 1,791 (New Position) | Filing |